Harnessing MRD for Optimal Patient Care

Time: 1:45 pm
day: Conference Day 2

Details:

  • MRD applications in clinical settings as a monitoring biomarker and surrogate endpoint
  • How MRD has assisted clinical decision-making and helped with the success of clinical development in oncology
  • Future outlook for how MRD can further advance cancer therapies

Speakers: